DGAP-Adhoc: SHOP APOTHEKE EUROPE raises full year 2020 guidance.
| DGAP-Ad-hoc: SHOP APOTHEKE EUROPE N.V. / Key word(s): Change in Forecast/Forecast
SHOP APOTHEKE EUROPE raises full year 2020 guidance.
23-Jul-2020 / 18:42 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
SHOP APOTHEKE EUROPE raises full year 2020 guidance. According to preliminary calculations, SHOP APOTHEKE EUROPE has significantly improved its key earnings figures in the second quarter of 2020 in line with the increased business volume. Based on the developments in the first and second quarters and against the background of an overall slightly improved visibility for the remaining part of the year, SHOP APOTHEKE EUROPE is lifting its guidance for the 2020 financial year. For the full year, the Management Board now expects a sales growth of at least 30% compared to the financial year 2019 (previously: at least 20%) and a positive adjusted EBITDA margin in the range of 1-2% (previously: a positive adjusted EBITDA). SHOP APOTHEKE EUROPE will publish the full report for the first half of 2020 on August 6, 2020. Contact: rikutis consulting Thomas Schnorrenberg Cel: +49 151 46 53 13 17 E-Mail: [email protected]
23-Jul-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|
| Language: | English | | Company: | SHOP APOTHEKE EUROPE N.V. | | Dirk Hartogweg 14 | | 5928 LV Venlo | | Netherlands | | Phone: | 0800 - 200 800 300 | | Fax: | 0800 - 90 70 90 20 | | E-mail: | [email protected] | | Internet: | www.shop-apotheke-europe.com | | ISIN: | NL0012044747, DE000A19Y072 | | WKN: | A2AR94, A19Y07 | | Indices: | SDAX | | Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange | | EQS News ID: | 1100793 |
| | | End of Announcement | DGAP News Service |
1100793 23-Jul-2020 CET/CEST 
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023e |
| Umsatzerlöse1 |
283,99 |
539,71 |
701,01 |
968,06 |
1.060,32 |
1.204,35 |
1.798,76 |
| EBITDA1,2 |
-12,14 |
-15,56 |
-18,58 |
15,20 |
-38,73 |
-29,66 |
39,99 |
| EBITDA-Marge3 |
-4,27 |
-2,88 |
-2,65 |
1,57 |
-3,65 |
-2,46 |
|
| EBIT1,4 |
-19,20 |
-28,73 |
-33,45 |
-0,87 |
-65,70 |
-69,17 |
-17,30 |
| EBIT-Marge5 |
-6,76 |
-5,32 |
-4,77 |
-0,09 |
-6,20 |
-5,74 |
-0,96 |
| Jahresüberschuss1 |
-21,36 |
-33,61 |
-36,27 |
-16,77 |
-74,19 |
-77,65 |
-11,61 |
| Netto-Marge6 |
-7,52 |
-6,23 |
-5,17 |
-1,73 |
-7,00 |
-6,45 |
-0,65 |
| Cashflow1,7 |
-23,24 |
-23,54 |
-30,37 |
17,80 |
11,64 |
-29,11 |
61,46 |
| Ergebnis je Aktie8 |
-2,25 |
-2,79 |
-2,78 |
-1,17 |
-4,15 |
-4,32 |
-0,73 |
| Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: Mazars
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| Redcare Pharmacy |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| A2AR94 |
135,000 |
Halten |
2.746,24 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 75,00 |
0,00 |
0,00 |
-64,66 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 5,26 |
44,69 |
1,53 |
72,77 |
| Dividende '22 in € |
Dividende '23e in € |
Div.-Rendite '23e
in % |
Hauptversammlung |
| 0,00 |
0,00 |
0,00 |
17.04.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
| 25.04.2024 |
30.07.2024 |
05.11.2024 |
05.03.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| -2,92% |
11,00% |
3,05% |
49,90% |
|
|
SHOP APOTHEKE EUROPE N.V. NL0012044747